Petrányi G G, Benczur M, Varga M, Györffy G, Gyódi E, Onody K, Hollán R S
Ann Immunol Hung. 1979;19:93-104.
The authors' own investigations into the spontaneous lymphocyte-mediated cytotoxicity (SLMC) have been reviewed and discussed in th light of literary data. It is suggested that SLMC is a resultant of complex effects contributed by antibodies present in the human serum and those attached to the surface of lymphocytes as well as by spontaneous (sui generis) functions of effector cells. The lymphocytes eliciting SLMC belong to the "O" subpopulation, bear Fc receptors and are presumably, identical with "K" lymphocytes. In animal experiments, the authors have shown that the SLMC reaction directed againt a virus-induced tumour is under polygenetic control primarily governed by gene(s0 linked to the histocompatibility region. In man, similarly as in the mouse, SLMC was found to be a genetically-controlled lymphocyte function in which gene(s) linked to the HLA-A2 B12 or the HLA-A3 B7 haplotype may play a determining role. The authors' clinical observations indicate that LSMC represents an important part of the defense mechanism against malignancies and autoimmune diseases. Estimation and follow-up of SLMC may be useful in monitoring the clinical course.
作者对自发淋巴细胞介导的细胞毒性(SLMC)的自身研究已根据文献资料进行了回顾和讨论。有人认为,SLMC是由人血清中存在的抗体、附着在淋巴细胞表面的抗体以及效应细胞的自发(独特)功能所产生的复杂效应的结果。引发SLMC的淋巴细胞属于“O”亚群,带有Fc受体,大概与“K”淋巴细胞相同。在动物实验中,作者表明针对病毒诱导肿瘤的SLMC反应受多基因控制,主要由与组织相容性区域连锁的基因控制。在人类中,与在小鼠中一样,发现SLMC是一种受基因控制的淋巴细胞功能,其中与HLA - A2 B12或HLA - A3 B7单倍型连锁的基因可能起决定性作用。作者的临床观察表明,LSMC是对抗恶性肿瘤和自身免疫性疾病防御机制的重要组成部分。对SLMC的评估和随访可能有助于监测临床病程。